CAR T Therapy in Myeloma - Inside the Revolution | Krina Patel, MD

CAR T-cell therapy is transforming outcomes in multiple myeloma — and the revolution is just beginning. In this HealthTree Roundtable recording from Austin, Krina Patel, MD, shares how clinical trials pave the way for FDA approvals and why earlier use of CAR T therapy may improve long-term results for myeloma patients.

Discover where CAR T treatment fits today, how trial data is changing the standard of care, and what exciting advances are coming next in myeloma research.